Concepedia

Author

D.Th. Sleijfer

University of Groningen

Also Known As

D Sleijfer, D T Sleijfer, D Th Sleijfer, D. Sleijfer, D. T. Sleijfer, D. Th. Sleijfer, D.T Sleijfer, D.T. Sleijfer, D.Th Sleijfer, D.Th. Sleijfer

101

Publications

3K

Citations

33

H-Index

80

Concepts

All Affiliations

University of GroningenUniversity Medical Center Groningen
DS

About

D.Th. Sleijfer is an author at University of Groningen specializing in medicine, oncology, and urology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

33

1.4K

2

Engineering

2

2

58

3

Public Health

2

2

137

4

Health Sciences

1

1

37

5

Biostatistics

1

1

35

D.Th. Sleijfer

×

45

Publications

2.3K

Citations

29

H-Index

YearCitations

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.

A. Horwich, D.Th. Sleijfer, Sophie D. Fosså,

Journal of Clinical Oncology

1997

331

Early development of the metabolic syndrome after chemotherapy for testicular cancer

De Haas, Renske Altena, H.M. Boezen,

Annals of Oncology

2012

115

Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors.

J. M. Nijman, H. Schraffordt Koops, Jan A.M. Kremer,

Journal of Clinical Oncology

1987

102

Long-term Follow-up of Cardiovascular Risk Factors in Patients Given Chemotherapy for Disseminated Nonseminomatous Testicular Cancer

Jourik A. Gietema, D.Th. Sleijfer, P.H.B. Willemse,

Annals of Internal Medicine

1992

98

COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMA

G. Stoter, D.Th. Sleijfer, C. P. J. Vendrik,

The Lancet

1979

97

Effects of interleukin-3 after chemotherapy for advanced ovarian cancer

Bonne Biesma, PH Willemse, NH Mulder,

Blood

1992

87

A phase II study of oral etoposide in elderly patients with small cell lung cancer.

Egbert F. Smit, D. N. Carney, P Harford,

Thorax

1989

86

Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2

B. J. Kroesen, Jan Buter, D.Th. Sleijfer,

British Journal of Cancer

1994

84

High-dose etoposide for refractory malignancies: a phase I study.

PE Postmus, NH Mulder, D.Th. Sleijfer,

PubMed

1984

73

Familial testicular cancer in a single-centre population

D.J.A. Sonneveld, D.Th. Sleijfer, H. Schraffordt Koops,

European Journal of Cancer

1999

68

Page 1